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EFFECT OF A PRICE TRANSPARENCY INTERVENTION  
IN THE ELECTRONIC HEALTH RECORD ON CLINICIAN  
ORDERING OF INPATIENT LABORATORY TESTS
Mina S. Sedrak, Jennifer S. Myers, Dylan S. Small, Irving Nachamkin, Justin B. Ziemba, Dana Murray, Gregory W. Kurtzman,  
Jingsan Zhu, Wenli Wang, Deborah Mincarelli, Daniel Danoski, Brian P. Wells, Jeffrey S. Berns, Patrick J. Brennan,  
C. William Hanson, Jessica Dine, Mitesh S. Patel 
JAMA Internal Medicine, April 2017 
KEYFINDINGS 
Despite the promise of price transparency, clinicians did not change their ordering of inpatient lab tests when Medicare 
allowable fees were displayed in the electronic health record at the time of order entry.
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THE QUESTION
With estimates that nearly 30% of laboratory testing in the United States 
is wasteful, health systems are considering making clinicians more aware 
of the costs of the tests they order. Price transparency, at the time of 
ordering, may encourage clinicians to consider the cost of their decisions. 
This study sought to answer the question: if clinicians knew the cost of the 
tests they order in the hospital, would they change their ordering behavior?
THE STUDY
This year-long randomized clinical trial was conducted at three hospitals 
within the University of Pennsylvania Health System in Philadelphia. It 
analyzed the ordering practices of physicians, nurse practitioners, and 
physician assistants, but did not differentiate between these clinicians. 
The analysis included a one-year pre-intervention period and a one-year 
intervention period. The authors randomized 60 lab tests to two groups: 
one that displayed Medicare allowable fees at the time of order and the 
other that did not. 
The primary outcome was the number of tests ordered per patient-day, 
after adjusting for patient characteristics and other variables. The authors 
also looked at the associated fees per patient-day. 
The research team conducted subgroup comparisons of differences in 
ordering behavior for patients with varying comorbidities, for those who 
had an intensive care unit (ICU) stay, and for tests from the highest and 
lowest cost brackets. 
THE FINDINGS
The mean number of tests per patient day did not change significantly 
in the intervention group compared to the control group over time. As 
shown, the mean number of tests ordered per patient-day remained 
virtually unchanged in both the intervention and control group. Even after
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adjusting for other factors, there was no significant change in the mean 
number of tests ordered or mean fees attributable to the intervention.
In subanalyses, the authors found a relative decrease in test ordering for 
patients with an ICU stay and a relative increase for patients without an 
ICU stay, and relative decrease in test ordering of tests in the top-quartile 
of fees and a relative increase of tests in the bottom-quartile of fees.
THE IMPLICATIONS
Prior evidence has been inconsistent on the effectiveness of price 
transparency as a way to influence medical decision-making. This study 
provides further evidence that price transparency, by itself, is not likely to 
reduce ordering of wasteful tests in the hospital.
A number of explanations may account for these findings and point 
the way toward more effective interventions. First, the allowable fees in 
the intervention were displayed regardless of the clinical scenario. The 
presence of this information for appropriate tests may have diminished its 
impact when tests were inappropriate. Future efforts might target price 
transparency more selectively.
Second, the intervention might have had reduced salience because it did 
not consider clinician practice habits. In a qualitative analysis at one of the 
hospital sites, 91% of resident physicians reported that unnecessary lab 
testing was due to the habit of entering repeating daily lab test orders on 
the patient’s first day of admission. If repeating orders were entered at 
admission, the clinician would not need to place another order and thus 
would not be presented with price transparency information when it would 
be most salient. This might explain the effects of the intervention when 
patients had an ICU stay.  Because health care decisions are changing 
more rapidly in this setting, clinicians may be less likely to rely on repeating 
orders and therefore may have been exposed to the intervention more 
often. Pairing price transparency information with interventions reducing 
the use of repeating test orders could address this problem.
Third, clinicians’ prior beliefs about costs of each test might influence the 
effectiveness of the intervention. Clinicians may have previously believed 
that the cost of some tests was higher or lower than the displayed price. 
This could explain the small but significant decrease in ordering for the 
most expensive tests and the small but significant increase in ordering for 
the least expensive tests. Other ways to frame price transparency, such as 
comparisons of differences in price between options, using other forms 
of price, such as charges, or targeting only more expensive tests, may be 
needed.
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